← SynDRA

GSK-690693

SynDRA canonical compound SYN0014185 — structure-anchored drug synonym record

All known targets

• AKT3
• AKT1
• PRKCQ
• AKT2
• PRKCE
• PRKG1
• PRKD3
• PRKD1
• PRKCZ
• PRKCI
• PRKCH
• PRKCG

Mechanisms of action (all sources)

• AKT1 INHIBITOR
• AKT2 INHIBITOR
• Serine/threonine-protein kinase AKT inhibitor
• AKT3 INHIBITOR
• PRKACB INHIBITOR
• cAMP-dependent protein kinase (PKA) inhibitor
• PRKACA INHIBITOR
• PRKACG INHIBITOR
• PRKD3 INHIBITOR
• Protein kinase C (PKC) inhibitor
• PRKCI INHIBITOR
• PRKCA INHIBITOR

Cross-references

• PubChem CID: 16725726
• ChEMBL: CHEMBL494089
• DrugBank: DB12745
• ChEBI: 90677
• PDB: G93
• TTD: D0MS3Z
• LINCS BRD: BRD-K25325018

Synonyms

• GSK 690693
• GSK690693
• UNII-GWH480321B
• (S)-4-(2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-(piperidin-3-ylmethoxy)-1H-imidazo[4,5-c]pyridin-4-yl)-2-methylbut-3-yn-2-ol
• CHEBI:90677
• GWH480321B
• 4-[2-(4-Amino-1,2,5-oxadiazol-3-yl)-1-ethyl-7-[(3S)-3-piperidinylmethoxy]-1H-imidazo[4,5-c]pyridin-4-yl]-2-methyl-3-butyn-2-ol
• 4-{2-(4-Amino-1,2,5-Oxadiazol-3-Yl)-1-Ethyl-7-[(3s)-Piperidin-3-Ylmethoxy]-1h-Imidazo[4,5-C]pyridin-4-Yl}-2-Methylbut-3-Yn-2-Ol
• J-502225
• C21H27N7O3
• Gsk 690693
• RefChem:144530
• DTXCID10162042
• MFCD14105605
• G93
• compound 3g [PMID 18800763]
• -yn-2-ol
• SCHEMBL310452
• GTPL5196
• orb1300902
• pan-Akt inhibitor GS690693
• SCHEMBL29387832
• BDBM25013
• EX-A031
• GLXC-05503
• NSC766991
• NSC800766
• s1113
• AKOS015904356
• AT18727
• CCG-264825
• NSC-766991
• NSC-800766
• SDCCGSBI-0654451.P001
• NCGC00263181-01
• NCGC00263181-11
• AC-23166
• AS-16204
• BG174974